Product Images Buprenorphine And Naloxone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Buprenorphine And Naloxone NDC 0121-1018 by Pai Holdings, Llc Dba Pharmaceutical Associates, Inc. And Dba Pai Pharma, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - Buprenorphine Hydrochloride - buprenorphine naloxone 01

Chemical Structure - Buprenorphine Hydrochloride - buprenorphine naloxone 01

HCI stands for Human-Computer Interaction. It is a field that focuses on the design, evaluation, and implementation of interactive computing systems for human use. HCI combines principles and methods from computer science, psychology, anthropology, and other disciplines to study how humans interact with computers and how to design technology that is user-friendly and efficient. HCI encompasses a wide range of topics, including user interface design, usability testing, user experience, and accessibility. Its goal is to improve the interaction between humans and computers, making technology more intuitive and accessible for all users.*

Chemical Structure - Naloxone Hydrochloride Dihydrate - buprenorphine naloxone 02

Chemical Structure - Naloxone Hydrochloride Dihydrate - buprenorphine naloxone 02

Figure 3 - buprenorphine naloxone 03

Figure 3 - buprenorphine naloxone 03

2 mg/0.5 mg Sublingual Tablet 30-count Bottle Label - buprenorphine naloxone 04

2 mg/0.5 mg Sublingual Tablet 30-count Bottle Label - buprenorphine naloxone 04

The description is as follows: "Each tablet contains Buprenorphine and Naloxone. The tablets are manufactured by Ethypharm S.A in France and distributed by PA| Pharma. The tablets are sublingual and are available in a 2mg/0.5mg dosage. The usual dosage should be determined based on the product information. The tablets should be stored at a temperature of 20°C to 25°C. The medication guide is available for dispensing to each patient. The tablets should be kept out of reach of children. The GTIN (Global Trade Item Number) is 0301211018304."*

8 mg/2 mg Sublingual Tablet 30-count Bottle Label - buprenorphine naloxone 05

8 mg/2 mg Sublingual Tablet 30-count Bottle Label - buprenorphine naloxone 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.